傳媒專區
傳媒專區 > 媒體報導 > 公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃 / Citizens unaware of cancer treatment costs

公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃 / Citizens unaware of cancer treatment costs

21-07-2018

公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃

 

 
本港公營醫療系統一直被指超出負荷,出現病人輪候時間長、醫護人手不足等問題。在香港,癌症是頭號殺手,每10個死亡的港人,就有3個死於癌症。但有調查發現,港人低估在公立醫院治療癌症費用,逾五成人未有為未來癌症治療開支作準備。

 

香港執業專科醫生協會和病人組織「癌症資訊網」進行了一項調查,分別訪問100名癌症病人及501名非癌症患者。調查發現,受訪港人認為在公立醫院接受癌症治療,所需費用平均為1.35萬元,但癌症患者調查顯示,在公立醫院治療晚期癌症自費藥物費用,平均需付26.7萬元,比普通市民的預計多19倍。

另外,只有約四成人為未來癌症治療開支作準備,但當中約兩成人以強積金或退休金作準備。

組織建議,政府和市民均應儘早開展未來癌症治療規劃,應對日益增加的癌症治療開支。

 

——————————————————————————————————-

Citizens unaware of cancer treatment costs

 

Hongkongers lack awareness of the full cost of getting cancer treatment, according to a survey.

The Cancer Information Hong Kong Charity Foundation interviewed 500 people and asked them how much they thought would be the overall cost of terminal stage colorectal cancer treatment.

The respondents expected the cost of treatment in the vicinity of HK$60,000 on average at public hospitals.

But the actual cost could exceed HK$270,000 and the amount still doesn’t include target therapy and immunotherapy since the Hospital Authority does not offer these services for free.

Poll respondents estimated cancer treatment in private hospitals to cost HK$400,000, but the actual cost is more than three times higher at HK$1.3 million.

Alan Ng Wai-lun, the foundation’s chairman, said more than half of the survey respondents have revealed that they were not setting aside any funds for cancer treatments.

Among the poll respondents, 57 percent said they have prepared for cancer by setting up savings. The rest said they would rely on medical insurance, the Mandatory Provident Fund and financial investments.

Asked what they would do if their insurance cover fails to pay for the costs of cancer treatment, 69 percent of the respondents said they would opt for cheaper public hospital services, and 11 percent said they would sell their apartments to raise funds.

The foundation also surveyed 100 cancer patients and 56 percent of the respondents said they had heard stories about fellow cancer sufferers forced to terminate treatments as they could no longer afford them.

Under the Voluntary Healthcare Insurance Scheme, which will be launched next year, cancer patients can claim a maximum of HK$80,000 for therapies.

Clinical oncology specialist Maverick Tsang Wai-kong said most target therapies cost between HK$30,000 and HK$40,000 per treatment.

Jeffrey Pong Chiu-fai of the Hong Kong Practicing Specialists Association has admitted that cancer services at public hospitals were often fully occupied.

“There are only around 100 clinical oncology specialists under the Hospital Authority and the doctor-patient ratio is one to 2,172,” he said.

 

文章來自: (中) HK01     (Eng) The Standard

 

 

 

城中活動

2025-05-27 10:00 上午 「Re:Start 我仲掂」舍區嘉年華
2025-05-21 2:00 下午 民航處航空教育徑導賞團

疑難排解

會員註冊


或許你會想看
【中西醫結合治療】推動香港中西醫結合治療—肺癌交流研討會 演講報告
在很多的病症上,西醫和中醫都可以發揮互補角色。在癌症治療路途上,中西醫結合治療亦是大部分癌症病人的選項。「癌症 […]
【家支援醫事講】鼻咽癌 ——講座回顧
【鼻咽癌免疫治療—-講座回顧】 感謝臨床腫瘤科專科李浩勳醫生為大家深入講解鼻咽癌的早期與晚期症狀、 […]
容許犯錯:成長的必經之路
多謝@drip_music_records 的邀請、有機會和幾位音樂達人分享我對藝術治療的一些看法,相信再多的 […]
立體定位放射治療小冊子 出版咗啦
癌症資訊網慈善基金 聯同 Hong Kong SBRT Study Group 合作的立體定位放射治療(SBR […]
基因檢測好有用 幫你對症下藥治療轉移性大腸癌
隨著醫學不斷發展,近年有愈來愈多新藥面世,晚期的轉移性大腸癌的治療亦出現很大的改變,特別對腫瘤細胞進行基因檢測 […]
2025 「聊 • 癒」 : 癌症病人服務計劃
不知宣告患癌那一刻,患者心裏在想什麼:會被一股恐惧感攫住?哭鬧不安?精神萎靡?還是食不知味?在那一秒,人是脆弱 […]
【家支援】鼻咽癌免疫治療——講座回顧
感謝臨床腫瘤科專科李浩勳醫生為大家深入講解鼻咽癌的早期與晚期症狀、免疫治療技術及預防策略,同時也感謝家支援,讓 […]
港大醫學院揭示胃癌早期突變及風險因素 開發癌前模型推動胃癌預防研究
香港大學李嘉誠醫學院(港大醫學院)臨床醫學學院病理學系的研究團隊近期兩項創新研究在理解胃癌最早期發展方面取得重 […]
港大醫學院全球首創光敏混合型免疫療法 突破癌症治療
香港大學李嘉誠醫學院(港大醫學院)的研究團隊成功開發突破性癌症免疫新療法,名為光敏混合型γδ-T細胞外泌體(醫 […]
【癌症照護】一齊支持4月9日首個 「世界心理腫瘤日」 !
生病是一個艱難的過程,尤其是癌症患者,面對病痛和治療副作用,身心皆受嚴峻的考驗。為了加強對癌症病人心理照護的重 […]
【腦腫瘤關注月】甚麼是腦轉移|張卓文醫生
  腦轉移是指癌細胞源於其他部位經過血液擴散到腦部,有別於腦癌(一般指腦部原發性的癌症)。腦轉移在晚 […]
醫院管理局推動收費改革 理順醫療服務 加強保障病人
醫院管理局(醫管局)三月二十五日公布,已經完成公營醫療收費改革檢討,向醫務衞生局提交收費改革政策建議,並已顧及 […]